109
Views
71
CrossRef citations to date
0
Altmetric
Research Article

The Role of Phosphotriesterases in the Detoxication of Organophosphorus Compounds

&
Pages 21-57 | Published online: 29 Sep 2008

References

  • World Health Organisation, Properties and analyti- cal methods. In: World Health Organisation, Ed., Organophosphorus Insecticides: A General Introduc- tion. Geneva: 1986, 23–29.
  • Davis, C. S. and Richardson, R. J., Organophospho- rus Compounds. In: Spencer, P. S. and Schaumburg, H. H., Eds., Experimental and Clinical Neurotoxicol- ogy, Baltimore, 1980, 527–544.
  • Sultatos, L. G., Mammalian toxicology of organo- phosphorus pesticides. J. Toxicol. Environ. Health., 43, 271–289, 1994.
  • Repetto, M., Aspectos toxicológicos de las armas químicas. Rev. Toxicol., 8, 526, 1991.
  • Aldridge, W. N. and Reiner, E., Acylated amino acids in inhibited B-esterases. In: Neuberger, A. and Tatum, E. L., Eds., Enzyme Inhibitors as Substrates. Amsterdam: North-Holland Publishing, 1972, 170– 175.
  • World Health Organisation, Metabolism and mode of action. In: World Health Organisation, Ed., Orga- nophosphorus Insecticides: A General Introduction. Geneva, 1986, 39–48.
  • World Health Organisation, Effects of organophos- phorus insecticides on the nervous system. In: World Health Organisation, Ed., Organophosphorus Insecti- cides: A General Introduction. Geneva, 1986, 39– 48.
  • Lotti, M., The pathogenesis of organophosphate poly- neuropathy. Crit. Rev. Toxicol., 21, 465–487, 1992.
  • Barril, J. and Carrera M. V., Polineuropatía retardad inducida por organofosforados: una gran desconocida. Med. Clin., 92, 787–793, 1989.
  • Lotti, M., The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol., 21, 465–487., 1992.
  • Johnson, M. K., The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemi- cal and toxicological applications. Rev. Biochem. Toxicol., 4, 141–212., 1982.
  • AbouDonia, M. B., The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxic- ity (OPIDN). Chem. Biol. Interact., 87, 383–393, 1993.
  • AbouDonia, M. B., Involvement of cytoskeletal pro- teins in the mechanisms of organophosphorus ester- induced delayed neurotoxicity. Clin. Exp. Pharmacol. Physiol., 22, 358–359, 1995.
  • Gupta, R. P. and AbouDonia, M. B., Neurofilament phosphorylation and [125I]calmodulin binding by Ca2+/ calmodulin-dependent protein kinase in the brain sub- cellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hen. Neurochem. Res., 20, 1095–1105, 1995.
  • Senanayake, N. and Karalliedde, L., Neurotoxic effects of organophosphorus insecticides. An inter- mediate syndrome. N. Engl. J. Med., 316, 761–763, 1987.
  • DeBleecker, J. L., The intermediate syndrome in organophosphate poisoning: an overview of experi- mental and clinical observations. J. Toxicol., Clin. Toxicol., 33, 683–686, 1995.
  • DeBleecker, J., Lison, D., VanDenAbeele, K., Willems, J., and DeReuck, J., Acute and subacute organophosphate poisoning in the rat. Neurotoxicology, 15, 341–348, 1994.
  • Konno, N., Fukuto, T. R., and Imamura, T., Lung injury and delayed toxicity produced by O,S,S- trimethyl phosphorodithioate, an impurity of malathion. Toxicol. Appl. Pharmacol., 75, 219–228, 1984.
  • Nemery, B. and Aldridge, W. N., Studies on the metabolism of the pneumotoxin O,S,S-trimethyl phosphorodithioate. II. Lung and liver slices. Biochem. Pharmacol., 37, 3717–3722, 1988.
  • Nemery, B. and Aldridge, W. N., Studies on the metabolism of the pneumotoxin O,S,S-trimethyl phosphorodithioate. I. Lung and liver microsomes. Biochem. Pharmacol., 37, 3709–3715, 1988.
  • Carrington, C. D., Lapadula, D. M., and AbouDonia, M. B., Acceleration of anterograde ax- onal transport in cat sciatic nerve by diisopropyl phosphorofluoridate. Brain. Res., 476, 179–182, 1989.
  • Gupta, R. P., AbdelRahman, A., Wilmarth, K. W., and AbouDonia, M. B., Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hen. Biochem. Pharmacol., 53, 12, 1799–1806, 1997
  • Moretto, A., Lotti, M., Sabri, M. I., and Spencer, P. S., Progressive deficit of retrograde axonal trans- port is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J. Neurochem., 49, 1515–1522, 1987.
  • Blasiak, J., Changes in membrane fluidity evoked by organophosphorus insecticide bromfenvinfos and its methylated analogue. Comp. Biochem. Physiol., 110C, 1521, 1995.
  • Blasiak, J., Changes in the fluidity of model lipid membranes evoked by the organophosphorus insecti- cide methylbromfenvinfos. Acta. Biochim. Pol., 40, 3941, 1993.
  • Blasiak, J., Parathion and methylparathion-altered flu- idity of native and model membranes. Pestic. Biochem. Physiol., 45, 7280, 1993.
  • Blasiak, J., Protective action of cholesterol against changes in membrane fluidity induced by methyl- parathion. Acta Biochim. Pol., 40, 35–38, 1993.
  • AntunesMadeira, M. C., Videira, R. A., and Madeira, V. M., Effects of parathion on membrane organization and its implications for the mechanisms of toxicity. Biochim. Biophys. Acta, 1190, 149–154, 1994.
  • Gutiérrez, L. M., Sogorb, M. A., Vilanova, E., and Viniegra, S., The role of nicotinic receptors and cal- cium channela in mipafox induced inhibition of cat- echolamine release in bovine chromaffin cells. Environ. Toxicol. Pharmacol., 1, 241–247, 1996.
  • Ehrich, M., Intropido, L., and Costa, L. G., Inter- action of organophosphorus compounds with musca- rinic receptors in SH-SY5Y human neuroblastoma cells. J. Toxicol. Environ. Health., 43, 51–63, 1994.
  • Bush, D. M., Lehning, E. J., and Bursian, S. J., The effects of diisopropylphosphorofluoridate (DFP) on the ganglioside profile in the chicken (Gallus domesticus) hindbrain. Neurotoxicology, 16, 55–62, 1995.
  • Blasiak, J., Allosteric inhibition of the (Na+ + K+)- ATPase by parathion and methylparathion. Pestic. Biochem. Physiol., 54, 40–47, 1996.
  • Blasiak, J., Inhibition of erythrocyte membrane (Ca2+ + Mg2+)-ATPase by the organophosphorus in- secticides parathion and methylparathion. Comp. Biochem. Physiol., 110C, 119–125, 1995.
  • KnothAnderson, J., Veronesi, B., Jones, K., Lapadula, D. M., and AbouDonia, M. B., Triphenyl phosphite-induced ultrastructural changes in bovine adreno-medullary chromaffin cells. Toxicol. Appl. Pharmacol., 112, 110–119, 1992.
  • Richburg, J. H. and Kauffman, F. C., Diisopropyl fluorophosphate inhibits receptor-activated Ca2+ in- flux in isolated rat hepatocytes. Toxicol. Appl. Pharmacol., 126, 178–185, 1994.
  • Whitney, K. D., Seidler, F. J., and Slotkin, T. A., Developmental neurotoxicity of chlorpyrifos, cellular mechanisms. Toxicol. Appl. Pharmacol., 134, 53–62, 1995.
  • Rodrigues, M. A., Fernandes, M. J., and Angelo, M. D., Lactate dehydrogenase isoenzymes in mam- malian cells exposed to isophenphos. Biomed. Environ. Sci., 8, 18–22, 1995.
  • Pala, I., Vig, P. J., Desaiah, D., and Srinivasan, A., In vitro effects of organophosphorus compounds on calmodulin activity. J. Appl. Toxicol., 11, 391–395, 1991.
  • Oehme, F. W., Effects of pesticides on domestic animals. vol. 1. In: Hayes, W. J., Jr. and Laws, E. R., Jr., Eds., Handbook of Pesticide Toxicology. Aca- demic Press, England, 1991, 453–461.
  • International Union of Biochemistry, Enzyme no- menclature. In: Webb, E. C., Eds., Recommendations of the Nomenclature Committee of the International Union of Biochemistry. Academic Press, England, 1984.
  • Aldridge, W. N., An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and identity with the A-esterase of mammalian sera. Biochem. J., 53, 117– 124, 1953.
  • Bergman., F., Segal, R., and Rimon, S., New type of esterases in hogkidney extract. Biochem. J., 67, 481– 486.
  • Pen, J. and Beintema, J. J., Nomenclature of es- terases. Biochem. J. Lett., 240, 933, 1986.
  • International Union of Biochemistry, Enzyme no- menclature. Eur. J. Biochem., 179, 511–515, 1989.
  • Walker, C. H., The develpment of an improved sys- tem of nomenclature and classification of esterases. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G., Eds., Enzymes Hydrolysing Organophosphorus Com- pounds. Ellis Horwwod Limited, England, 1989, 236– 245.
  • Mackness, M. I., Thompson, H. M., Hardy, A. R., and Walker, C. H., Distinction between A-esterases and arylesterases implication for esterase classifica- tion. Biochem. J., 245, 293–296, 1987.
  • Aldridge, W. N., Hoskin, F. C. G., Reiner, E., and Walker, C. H. Suggestions for a nomenclature and classification of enzymes hydrolysing organophos- phorus compounds. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G., Eds., Enzymes Hydrolysing Organophosphorus Compounds. Ellis Horwwod Lim- ited, England, 1989, 246–253.
  • International Union of Biochemistry., Enzyme no- menclature. In: Webb, E. C., Eds., Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. Aca- demic Press Inc., San Diego (USA), 1992.
  • Reiner, E., Recommendations of the IUBMB No- menclature Committee Comments Concerning Clas- sification and Nomenclature of Esterases Hydrolysing Organophosphorus Compounds. Chem. Biol. Inter- act., 87, 15–16, 1993.
  • Landis, W. G., Distribution and nature of the aquatic organophosphorus acid anhydrases: enzymes for or- ganophosphate detoxification. Rev. Aquat. Sci., 5, 267– 285, 1991.
  • Walker, C. H., The classification of esterases which hydrolyse organophosphates—recent developments. Chem. Biol. Interact., 87, 17–24, 1993.
  • Mazur, A., An enzyme in animal tissues capable of hydrolysing the organophosphorus-fluoride bond of alkyl fluorophosphateses. J. Biol. Chem., 164, 271– 289, 1946.
  • Furlong, C. E., Richter, R. J., Chapline, C., and Crabb, J. W., Purification of rabbit and human serum paraoxonase. Biochemistry, 30, 10133–10140, 1991.
  • Gan, K. N., Smolen, A., Eckerson, H. W., and La Du, B. N., Purification of human serum paraoxonase arylesterase—evidence for one esterase catalyzing both activities. Drug Metab. Dispos., 19, 100–106, 1991.
  • Hassett, C., Richter, R. J., Humbert, R., Chapline, C., Crabb, J. W., Omiecinski, C. J., and Furlong, C. E., Characterization of cDNA clones encoding rabbit and human serum paraoxonase—the mature protein retains its signal sequence. Biochemistry, 30, 10141–10149, 1991.
  • La Du, B. N., Adkins, S., Kuo, C. L., and Lipsig, D., Studies on human serum paraoxonase/arylesterase. Chem. Biol. Interact., 87, 25–34, 1993.
  • Pellín, M. C., Moretto, A., Lotti, M., and Vilanova, E., Distribution and some biochemical properties of rat paraoxonase activity. Neurotoxicol. Teratol., 12, 611–614, 1990.
  • Furlong, C. E., Costa, L. G., Hassett, C., Richter, R. J., Sundstrom, J. A., Adler, D. A., Disteche, M., Omiecinski, C. J., Chapline, C., Crabb, J. W., and Humbert, R., Human and rabbit paraoxonases purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem. Biol. Interact., 87, 35–48, 1993.
  • De Bisschop, H. C. J. V., De Meerleer, W. A. P., Van Hecke P. R. J., and Willems, J. L., Stereo- selective hydrolysis of soman in human plasma and serum. Biochem. Pharmacol., 36, 3579–3585, 1987.
  • De Bisschop, H. C., Mainil, J. G., and Willems, J. L., In vitro degradation of four isomers of soman in human serum. Biochem. Pharmacol., 34, 1895–1900, 1985.
  • Becker, E. L. and Barbaro, J. F., The enzymatic hydrolysis of p-nitrophenyl ethyl phosphonates by mammalian plasmas. Biochem. Pharmacol., 13, 1219– 1227, 1964.
  • DíazAlejo N., Sogorb, M. A., Vicedo, J. L., and Vilanova, E., A stereospecific esterase hydrolyzing an organophosphorus compound. Toxicol. Lett., Supplement 1/74, 19, 1994.
  • Reiner E., Simeon, V., and ShrinjericSpoljar, M., Hydrolysis of O,O-dimethyl-2,2-dichlorovinyl phos- phate (DDVP) by esterases in parasitic helminths and in vertebrate plasma and erythrocytes. Comp. Biochem. Physiol., 66C, 149–152, 1980.
  • Brealey, C., Walker, C., and Baldwin, B., A-es- terase activities in relation to the differential toxicity of pirimiphos-methyl to birds and mammals. Pestic. Sci., 11, 546–554, 1980.
  • Traverso, R., Moretto, A., and Lotti, M., Humn serum A-esterases, hydrolysis of O,O-dimethyl-2,2- dichlorovinyl phosphate. Biochem. Pharmacol., 1989; 38, 671–676.
  • Gonzalvo, M. C., Estudio de la actividad hidrolizante de paraoxon (paraoxnasa) de hígado humano: distribución subcelular y caracterización bioquímica. Ph.D. dissertation, Universidad de Granada, Granada, Spain, 1996.
  • Pla, A. and Johnson, M. K., Degradation by rat tissues in vitro of organophosphorus esters which in- hibit cholinesterase. Biochem. Pharmacol., 38, 1527– 1533, 1988.
  • Pond, A. L., Chambers, H. W., and Chambers, J. E., Organophosphate detoxication potential of vari- ous rat tissues via A-esterase and aliesterase activities. Toxicol. Lett., 78, 245–252, 1995.
  • Gil, F., Gonzalvo, M. C., Hernández, A. F., Villanueva, E., and Pla, A., Differences in the ki- netic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver. Biochem. Pharmacol., 48, 1559–1568, 1994.
  • DiazAlejo, N., Pellín, M. C., Vicedo, J. L., and Vilanova, E., Hen liver and plasma can metabolize hexylDCP phosphoramidate at a rate comparable to that of rat. Neurotoxol. Teratol., 12, 615–617, 1990.
  • Pond, A. L., Coyne, C. P., Chambers, H. W., and Chambers, J. E., Identification and isolation of two rat serum proteins with A-esterase activity toward paraoxon and chlorpyrifos-oxn. Biochem. Pharmacol., 52, 363–369, 1996.
  • Chemnitius, J. M., Losh, H., Losh, K., and Zech, R., Organophosphate detoxicating hydrolases in dif- ferent vertebrate species. Comp. Biochem. Physiol., 76C, 85–93, 1983.
  • Gil, F., Pla, A., Gonzalvo, M. C., Hernández, A. F., and Villanueva, E., Partial purification of paraoxonase from rat liver. Chem. Biol. Interact., 87, 69–75, 1993.
  • Gil, F., Pla, A., Gonzalvo, M. C., Hernández, A. F., and Villanueva, E., Rat liver paraoxonase-subcellu- lar distribution and characterization. Chem. Biol. In- teract., 87, 149–154, 1993.
  • Rodrigo, L., Gil, F, Hernández, A. F., Marina, A., Vázquez, J., and Pla, A., Purification and character- ization of paraoxon hydrolase from rat liver. Biochem. J., 821, 595–601, 1997.
  • Little, J., Broomfield, C., FoxTalbot, M., Boucher, L., MacIver, B., and Lenz, D., Partial characteriza- tion of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem. Pharmacol., 38, 23–29, 1989.
  • Hoskin, F. C. G. and Prusch, R. D., Characteriza- tion of a DFPhydrolysing enzyme in squid posterior salivary gland by use of soman, DFP and manganous ion. Comp. Biochem. Physiol., 75, 17–20, 1983.
  • Adie, P. A. and Tuba, J., The intracelular localiza- tion of liver and kidney sarinase. Can. J. Biochem. Physiol., 36, 21–24, 1958.
  • Hoskin, F. C. and Steinmann, K. E., The detoxica- tion of organophosphorus compounds: A tale of two enzymes—or are. Proc. Int. Conf. Env. Haz. Agrochem., 1, 434–447, 1983.
  • Forsyth, C. and Chambers, J., Activation and deg- radation of the phosphorothionate insecticides par- athion and EPN by rat brain. Biochem. Pharmacol., 38, 1597–1603, 1986.
  • Westra, B. D. and Landis, W. G., Initial character- ization of the organophosphate acid anhydrase activ- ity of the chicken, Gallus domesticus. Comp. Biochem. Physiol., 102C, 253–265, 1992.
  • Landis, W. G. and Shough, N. J., Discovery, initial characterization and comparison of the organophos- phate acid hydrolyzing activities of the bobwhite quai, stilt and mallard. Comp. Biochem. Physiol., 102C, 527–535, 1992.
  • Boone, J. S. and Chambers, J. E., Biochemical fac- tors contributing to toxicity differences among chlorpyrifos, parathion, and methyl parathion in mosquitofish (Gambusia affinis). Aquatic. Toxicol., 39, 333–343, 1997.
  • KopecSmyth, K., Deschamps, J. R., Loomis, L. D., and Ward, K. B., A partial primary structure of squid hepatopancreas organophosphorus acid anhydrolase. Chem. Biol. Interact., 87, 49–54, 1993.
  • Wang, F., Xiao, M. Z., and Mu, S. F., Purification and properties of a diisopropyl-fluorophosphatase from squid Todarodes-pacificus-Steenstrup. J. Biochem. Toxicol., 8, 161–166, 1993.
  • Anderson, R. S., Durst, H. D., and Landis, W. G., Organofluorophosphate-hydrolysing activity in an es- tuarine clam, Rangia cuneata. Comp. Biochem. Physiol., 91C, 575–578, 1988.
  • Noellgen, R. M. and Landis, W. G., Identification and characterization of the organophosphate acid an- hydrase activity of the Blue Mussel, Mytilus edulis. Comp. Biochem. Physiol., 102C, 615–623, 1992.
  • Watanabe, M., Takebe, S., and Kobashi, K., High paraoxon-hydrolyzing activity in organophosphorous insecticide-resistant mosquitoes. Chem. Pharmac. Bull., 39, 980–985, 1991.
  • Devonshire, A. L., Role of esterases in resistance of insects to insecticides. Biochem. Soc. Trans., 19, 755– 759, 1991.
  • Rowland, S. S., Speedie, M. K., and Pogell, B. M., Purification and characterization of a secreted recom- binant phosphotriesterase (Parathion Hydrolase) from Streptomyces lividans. Appl. Environ. Microbiol., 57, 440–444, 1991.
  • Mulbry, W. W. and Karns, F. S., Parathion hydro- lase specified by the Flavobacterium opd gene: rela- tionship between the gene and protein. J. Bacteriol., 171, 6740–6746, 1989.
  • Hoskin, F. C. G., Inhibition of a soman and diisopropylphosphorofluoridate (DFP)-detoxifying enzyme by mipafox. Biochem. Pharmacol., 34, 2069– 2072, 1985.
  • Hoskin, F. C. G., Gallo, B. J., Steeves, D. M., and Walker, J. E., Stereoselectivity of soman detoxica- tion by organophosphorus acid anhydrases from Es- cherichia coli. Chem. Biol. Interact., 87, 269–278, 1993.
  • De Frank, J. J. and Cheng, T. C., Purification and properties of an organophosphorus acid anhydrase from a halophilic bacterial isolate. J. Bacteriol., 173, 1938–1943, 1991.
  • Add Alla, M. H., Phosphodiesterase and phos- photriestease in Rhizobium and Bradyrhizobium strains and their roles in the degradation of organophospho- rus pesticides. Lett. Appl. Microbiol., 19, 240–243, 1994.
  • Landis, W. G., Savage, R. S., and Hoskin, F. C. G., An organofluorophosphate-hydrolyzing activity in Tetrahymena thermophila. J. Protozool., 32, 517–519, 1985.
  • Landis, W. G., Haley, M. V., and Johnson, D. W., Kinetics of the DFPase activity in Tetrahimena thermophila. J. Protozool., 33, 216–218, 1986.
  • Landis, W. G., Chester, N. A., Haley, M. V., Johnson, D. W., Tauber, R. M., and Durst, H. D., Alternative substrates and an inhibitor of the organo- phosphate acid anhydrase activities of the protozoan, Tetrahymena thermophila. Comp. Biochem. Physiol., 92C, 211–216, 1989.
  • Landis,W. G., Haley, D. M., Haley, M. V., Johnson, W., Durst, H. D., and Savage, R. E., Jr., Discov- ery of multiple organofluorophosphate hydrolyzing activities in the protozoan Tetrahymena thermophila. J. Appl. Toxicol., 7(1),35–41, 1987.
  • De Frank, J. J., Beaudry, W. T., Cheng, T. C., Harvey, S. P., Stroup, A. N., and Szafraniec, L. L., Screening of halophilic bacteria and alteromonas spe- cies for organophosphorus hydrolyzing enzyme activ- ity. Chem. Biol. Interact., 87, 141–148, 1993.
  • Dumas, D. P., Wild, J. R., and Raushel, F. M., Diisopropylfluorophosphate hydrolysis by a phos- photriesterase from Pseudomonas diminuta. Bio- technol. Appl. Biochem., 11, 235–243, 1989.
  • Dumas, D. P., Durst, H. D., Landis, W. G., Raushel, F. M., and Wild, J. R., Inactivation organophospho- rus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch. Biochem. Biphys., 277, 155–159, 1990.
  • Dumas, D. P., Caldwell, S. R., Wild, J. R., and Raushel, F. M., Purification and properties of the phosphotriesterase from Pseudomonas diminuta. J. Biol. Chem., 264, 19659–19665, 1989.
  • Lai, K., Stolowich, N. J., and Wild, J. R., Character- ization of P-S bond hydrolysis in organophos- phorothioate pesticides by organophosphorus hydro- lase. Arch. Biochem. Biophys., 318, 5964, 1995.
  • Chae, M. Y., Postula, J. J., and Raushel, F. M., Stereospecific enzymatic hydrolysis of phosphorus- sulfur bonds in chiral organophosphate triesters. Bioorg. Medicinal Chem. Lett., 4, 1473–1478, 1994.
  • Hoskin, F. C. G., Walker, J. E., Dettbarn W. D., and Wild, J. R., Hydrolysis of tetriso by an enzyme derived from Pseudomonas diminuta as a model for the detoxication of O-ethyl S-(2-diisopropyl- aminoethyl) methylphosphonothiolate (VX). Biochem. Pharmacol., 49, 711715, 1995.
  • Lewis, V. E., Donarski, W. J., Wild, J. R., and Raushel, F. M., Mechanism and stereochemical course at phosphorus of the reaction catalyzed by a bacterial phosphotriesterase. Biochemistry, 27, 1591–1597, 1988.
  • Dumas., D. P., Wild, J. R., and Raushel, F. M., Expression of Pseudomonas diminuta phospho- triesterase activity in the fall armyworm confers resis- tance to insecticides. Experientia, 46, 729–731, 1990.
  • Chae, M. Y., Omburo, G. A., Lindahl, P. A., and Raushel, F. M., Antiferromagnetic coupling in the binucleal metal cluster of manganese-substituted phosphotriesterase. J. Am. Chem. Soc., 115, 12173– 12174, 1993.
  • Lai, K. H., Dave, K. I., and Wild, J. R., Bimetallic binding motifs in organophosphorus hydrolase are important for catalysis and structural organization. J. Biol. Chem., 269, 1657916584, 1994.
  • Chae, M. Y., Omburo, G. A., Lindahl, P. A., and Raushel F. M., Utilization of cooper as a paramag- netic probe for the binuclear metal center of phosphotriesterase. Arch. Biochem. Biophys., 316, 765–772, 1995.
  • Vilanova, E., Johnson, M.K., and Vicedo, J. L., Interaction of some unsustituted phosphoramidate analogs of methamidophos (O,S-dimethyl phos- phorothioamidate) with acetylcholinesterase and neu- ropathy target esterase of hen brain. Pest. Biochem. Physiol., 28, 224–238, 1987.
  • Johnson, M. K., Vilanova, E. and Read D. J., Bio- chemical and clinical test of the delayed neuropathic potencial of some O-alkyl O-dichlorophenyl phosphoramidate analogues of methamidophos (O,S- dimethyl phosphorothioamidate). Toxicology, 54, 89– 100, 1989.
  • Reiner, E., Johnson, M. K., and Jokanovic, M., Hydrolysis of some organophosphorus dichlorophenyl esters by hen brain homogenates and rabbit serum compared with hydrolysis of paraoxon. Chem. Biol. Interact., 87, 127–131, 1993.
  • Uriel, A., Characterization des cholinesterases et d’autres esterases apres electrophorese et immuno- electroforese en gelose. I. Applications a l’etude des esterases du serum humain normal. Ann. Inst. Pas- teur., 191, 101–104, 1961.
  • Kitchen, B. J., Masters, C. J., and Winzor, D. J., Effects of lipid removal on the molecular size and kinetics properties of bovine plasma arylesterase. Biochem. J., 135, 93–99, 1973.
  • Don, M. M., Masters, C. J., and Winzor, D. J., Further evidence for the concept of bovine plasma arylesterase as a lipoprotein. Biochem. J. 151, 625– 630, 1975.
  • Mackness, M. I., and Walker, C. H., Partial purifi- cation and properties of sheep serum “A” esterases. Biochem. Pharmacol., 32, 2291–2296, 1983.
  • Mackness, M. I., Hallam, S. D., Peard, T., Warner, S., and Walker, C. H., The separation of sheep and human serum A-esterase activity into the lipoprotein fraction by ultracentrifugation. Comp. Biochem. Physiol., 83B, 675–677, 1985.
  • La Du, B. N., and Novais, J., Human serum organophosphatase: biochemical characteristicis and polymorphic inheritance. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G. Eds., Enzymes Hydrolys- ing Organophosphorus Compounds. Ellis Horwwod Limited, England, 1989, 41–52.
  • Blatter, M. C., James, R. W., Messmer, S., Barja, F., and Pometta, D., Identification of a distinct human high-density lipoprotein subspecies defined by a lipoproteinassociated protein, K-45. Identity of K-45 with paraoxonase. Eur. J. Biochem., 211, 871–879, 1993.
  • Kelso, G. J., Stuart, W. D., Richter, J., Furlong, C. E., JordanStarck, T. C., and Harmony, J. A., Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry, 33, 832–839, 1994.
  • Ohkawa, H., Mikami, N., Okuno, Y., and Miyamoto, J., Stereospecificity in toxicity of the optical isomers of EPN. Bull. Environ. Contam. Toxicol., 18, 534–540, 1977.
  • De Jong, L. P. A., Van Dijk, C., and Benschop, P., Stereoselective hydrolysis of soman and other chiral organophosphates by mammaliam phosphoryl- phosphateses. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G., Eds., Enzymes Hydrolysing Organo- phosphorus Compounds. Ellis Horwwod Limited, England, 1989, 65–78.
  • DíazAlejo, N., Estereoespecificidad de Enzimas Hidrolizantes de Diclorofenilfosforamidato Como Factor de su Mecanismo de Neurotoxicidad. Ph.D. dissertation, Universidad de Alicante, Alicante, Spain.
  • DíazAlejo, N. and Vilanova E., Chiral high-perfor- mance liquid chromatography and gas chromatogra- phy of the stereoisomers of O-hexyl, O-2,5- dichlorophenyl phosphoramidate. J. Chromatogr., 622, 179–186, 1993.
  • DíazAlejo, N., Sogorb, M. A., Vicedo, J. L., Carrera, V., Escudero, M. A., and Vilanova, E., Cuantificación y análisis de los estereoisómeros de hexil 2,5 diclorofenil fosforamidato tras ser hidrolizados por plasma de gallina. Rev. Toxicol., 10, 80.
  • DíazAlejo, N., Monroy, A., Vilanova, E., Vicedo,J. L., and Sogorb, M. A., A stereospecific phos- photriesterase in hen liver and brain. Chem. Biol. Interact., 108, 187–196.
  • Sogorb, M. A., Caracterización Bioquímica de la Actividad Hidrolizante de O-Hexil, O-2,5-diclorofenil Fosforamidato en Suero de Pollo y Conejo. Ph.D. dissertation, Universidad de Alicante, Alicante, Spain, 1997.
  • Sogorb, M. A., DíazAlejo, N., Pellín, M. C., and Vilanova, E., Inhibition and aging of neuropathy tar- get esterase by the stereoisomers of a phosphoramidate related to methamidophos. Toxicol. Lett., 93, 95–102, 1997.
  • Sogorb, M. A., DíazAlejo, N., Ñíguez, N., and Vilanova, E., Differences in the interaction between O-hexyl O-2,5-dichlorophenyl phosphoramidate ste- reoisomers and neuropathy target esterase. Toxicol. Lett., Suppl. 1/88, 24, 1996.
  • Benschop, H. P., Bijleveld, E. C., De Jong, L. P. A., Van deer Wiel, H. J., and Van Helden., H. P. M., Toxicokinetics of four stereoisomers of the nerve agent soman in atropinized rats. Influence of a soman simu- lator. Toxicol. Appl. Pharmacol., 90, 490–500, 1987.
  • Johnson, M. K., Vilanova, E., and Read, D. J., Anomalous biochemical responses in tests of the de- layed neuropathic potential of methamidophos (O,S- Dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues. Arch. Toxicol., 65, 618–624, 1991.
  • Sogorb, M. A., DíazAlejo, N., Vilanova, E., Vicedo,J. L., and Carrera, V., Effect of some metallic cat- ions and organic compounds on the O-hexyl O-2,5- dichlorophenyl phosphoramidate hydrolyzing activity in hen plasma. Arch. Toxicol., 67, 416–421, 1993.
  • Sogorb, M. A., DíazAlejo, N., Vilanova, E., Vicedo,J. L., and Carrera, V., Activadores e inhibidores de una actividad hidrolasa que destoxifica compuestos organofosforados en plasma de gallina. Rev. Toxicol., 10, 79, 1993.
  • Banzon, J. A., Kuo, J. M., Miles, B. W., Fischer, D. R., Stang, P. J., and Raushel, F. M., Mechanism- based inactivation of phosphotriesterase by reaction of a critical histidine with a ketene intermediate. Bio- chemistry, 34, 743–749, 1995.
  • Blankenship, J. N., AbuSoud, H., Francisco, W. A., Raushel, M. A., Fisher, D. R., and Stang, P. J., Mechanism-based inactivation of a bacterial phosphotriesterase by an alkynyl phosphate ester. J. Am. Chem. Soc., 113, 8560–8561, 1991.
  • Hong, S. B. and Raushel, F. M., Inhibitors directed toward the binuclear center of the phosphotriesterase. J. Enzy. Inhibit., 12, 191–203, 1997.
  • Banzon, J. A., Kuo, J. M., Fischer, D. R., Stang,P. J., and Raushel, F. M., Histidine-254 is essential for the inactivation of phosphotriesterase with the alkynyl phosphate esters and diethyl pyrocarbonate. Biochemistry, 34, 750–754, 1995.
  • Dumas, D. P. and Raushel, F. M., Chemical and kinetic evidence for an essential histidine in the phosphotriesterase from Pseudomonas diminuta. J. Biol. Chem., 265, 21498–21503, 1990.
  • Järv, J., Insight into putative mechanism of esterase acting simultaneously on carboxyl and phosphoryl compounds. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G., Eds., Enzymes Hydrolysing Organo-phosphorus Compounds. Ellis Horwwod Limited, England, 1989, 221–225.
  • Vitarius, J. A. and Sultatos, L. G., The role of calcium in the hydrolysis of the organophosphate paraoxon by human serum A-esterase. Life Sci., 56, 125–134, 1994.
  • DíazAlejo, N.; Sogorb, M. A., Vicedo, J. L., Barril, J., and Vilanova, E., Non-calcium-dependent activ- ity hydrolysing organophosphorus compounds in hen plasma. Comp. Biochem. Physiol., 107(C), 213–219, 1994.
  • Omburo, G. A., Kuo, J. M., Mullins, L. S., and Raushel, F. M., Characterization of the zinc binding site of bacterial phosphotriesterase. J. Biol. Chem., 267, 13278–13283, 1992.
  • Smolen, A., Eckerson, H. W., Gan, K. N., Hailat, N., and La Du, B. N., Characteristics of the geneti- cally determined allozymic forms of human serum paraoxonase/arylesterase. Drug. Metabolism. Dispos., 19, 107–112, 1991.
  • Aldridge, N. W., A-esterases and B-esterases in Per- spective. In: Enzymes hydrolysing organophosphorus compounds. In: Reiner, E., Aldridge, W. N., and Hoskin, F. C. G., Eds., Ellis Horwwod Limited, En- gland, 1989, 114.
  • Erdös, E. G. and Boggs, L. E., Hydrolysis of paraoxon in mammalian bood. Nature, 190, 716–717, 1961.
  • Sogorb, M. A., DíazAlejo, N., Escudero, M. A., and Vilanova, E., Phosphotriesterase activity identified in purified serum albumins. Arch. Toxicol., 72, 219– 226, 1998.
  • Sogorb, M. A., DíazAlejo, N., Vicedo, J. L., and Vilanova, E., Hen serum albumin hydrolyzes an or- ganophosphorus compound. Toxicol. Lett., Suppl. 1/ 88, 88, 1996.
  • Sogorb, M. A., Barril, J., Céspedes, M. V., Escudero,M. A., Ñíguez, N., Vicedo, J. L., and Vilanova, E., A new nondescribed organophosphorus hydrolase activity of serum albumin. Fundam. Appl. Toxicol., Suppl. 36, No.1, Part 2, 348, 1997.
  • Walker, C. H., Brealey, C. J., Mackness, M. I., and Johnston, G., Toxicity of pesticides to birdsthe enzy- mic factor. Biochem. Soc. Trans., 19, 741–745, 1991.
  • Sogorb, M. A., Vilanova, E., and DíazAlejo, N., The kinetics of O-hexyl O-2,5-dichlorophenyl phosphoramidate hydrolyzing activity in hen plasma. Chem. Biol. Interact., 87, 117–125, 1993.
  • Means, G. E. and Bender, M., Acetylation of human serum albumin by pnitrophenyl acetate. Biochemistry, 14, 4989–4994, 1975.
  • Vitarius, J. A. and Sultatos, L. G., Kinetic mecha- nism of the detoxification of the organophosphate paraoxon by human serum A-esterase. Drug. Metab. Dispos., 22, 472–478, 1994.
  • Lockridge, O., Blong, R. M., Masson, P., Froment,M. T., Millard, C. B., and Broomfield, C. A., A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Biochemistry, 36, 786–795, 1997.
  • Sorenson, R. C., PrimParmo, S. L., Kuo, C. L., Adkins, S., Lockridge, O., and La Du, B. N., Recon- sideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA, 92, 7187–7191, 1995.
  • Kuo, C. L. and La Du, B. N., Comparison of purified human and rabbit serum paraoxonases. Drug Metab. Dispos., 23, 935–944, 1995.
  • Furlong, C. E., Richter, R. J., Seidel, S. L., and Motulsky, A. G., Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet., 43, 230–238, 1988.
  • Eckerson, H, W., Wyte, C. M., and La-Du, B. N., Pharmacogenetic studies on human serum para- oxonase: relative paraoxonase arylesterase activities. Fed. Proc. Fed. Am. Soc. Exp. Biol., 40, 724, 1981.
  • Furlong, C. E., Richter, R. J., Seidel, S. L., and Motulsky, A. G., Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet., 43, 230–238, 1988.
  • Davies, H. G., Richter, R. J., Keifer, M., Broomfield,C. A., Sowalla, J., and Furlong, C. E., The effect of the human serum paraoxonase polymorphism is re- versed with diazoxon, soman and sarin. Nat. Genet., 14, 334–336, 1996.
  • Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., and Furlong, C. E., The molecular basis of the human serum paraoxonase ac- tivity polymorphism. Nat. Genet., 3, 73–76, 1993.
  • Adkins, S., Gan, K. N., Mody, M., and La Du,B. N., Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet., 52, 598–608, 1993.
  • Garin, M. C., James, R. W., Dussoix, P., Blanche, H., Passa, P., Froguel, P., and Ruiz, J., Paraoxonase polymorphism Met-Leu54 is associated with modi- fied serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest., 99, 62–66, 1997.
  • Eiberg, H., Mohr, J., Schmiegelon, K., Nielsen,L. S., and Williamson, R., Linkage relationships of paraoxonase (PON) with others markers: indication of PON-cystic fibrosis synteny. Clin. Genet., 25, 265– 271, 1985.
  • Tsui, L. C., Cystic fibrosis locus defines by a geneti- cally linked polymorphism DNA marker. Science, 230, 1054–1057, 1985.
  • Li, W. F., Matthews, C., Disteche, C. M., Costa, L. G., and Furlong, C.E., Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and de- velopmental expression. Pharmacogenetics., 7, 137– 144, 1997.
  • Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., and La-Du, B. N., The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics, 33, 498–507, 1996.
  • McDaniel, C. S., Harper, L. L., and Wild, J. R., Cloning and sequencing of a plasmidborne gene (opd) encoding a phosphotriesterase. J. Bacteriol., 170, 2306–2311, 1988.
  • Mulbry, W. W., Karns, J. S., Kearney, P. C., Nelson,J. O., McDaniel, C. S., and Wild, J. R., Identifica- tion of a plasmid-borne parathion hydrolase gene from Flavobacterium sp. by Southern hybridization with opd from Pseudomonas diminuta. Appl. Environ. Microbiol., 51(5),926–930, 1986.
  • Harper, L. L., McDaniel, C. S., Miller, C. E., and Wild, J. R., Dissimilar plasmids isolated from Pseudomonas diminuta MG and a Flavobacterium sp. (ATCC 27551) contain identical opd genes. Appl. Environ. Microbiol., 54, 2586–2589, 1988.
  • Benning, M. M., Kuo, J. M., Raushel, F. M., and Holden, H. M., Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry, 33, 15001–15007, 1994.
  • Omburo, G. A., Mullins, L. S., and Raushel, F. M., Structural characterization of the divalent cation sites of bacterial phosphotriesterase by Cd-113 NMR spec- troscopy. Biochemistry, 32, 9148–9155, 1993.
  • Kuo, J. M. and Raushel, F. M., Identification of the histidine ligands to the binuclear metal center of phosphotriesterase by site-directed mutagenesis. Biochemistry, 33, 4265–4272, 1994.
  • Van Hooke, J. L., Benning, M. M., Raushel, F. M., and Holden, H. M., Three-dimensional structure of the zinc-containing phosphotriesterase with the bound substrate analog diethyl 4-methylbenzylphosphonate. Biochemistry, 35, 6020–6025, 1996.
  • Mullins, l. S., Chae, M. Y., and Raushel, F. M., Phosphorus–31 NMR relaxation studies of diethyl p- metoxyphenyl phosphate bound to phosphotriesterase. Bioorg. Medicinal Chem. Letter, 5, 3067–3072, 1995.
  • Benning, M. M., Kuo, J. M., Raushel, F. M., and Holden, H. M., Three-dimensional structure of the binuclear metal center of phosphotriesterase. Biochem- istry, 34(25),7973–7978, 1995.
  • Hong, S. B., Kuo, J. M., Mullins, L. S., and Raushel,F. M., CO2 is required for the assembly of the bi- nuclear metal center of phosphotriesterase. J. Am. Chem. Soc., 117, 7580–7581, 1995.
  • Kuo, J. M., Chae, M. Y., and Raushel, F. M., Per- turbations to the active site of phosphotriesterase. Biochemistry, 36, 1982–1988, 1997.
  • Donarski, W. J., Dumas, D. P., Heitmeyer D. P., Lewis V. E., and Raushel, F. M., Structure-activity relationships in the hydrolysis of substrates by the phosphotriesterase from Pseudomonas diminuta. Bio- chemistry, 28, 4650–4655, 1989.
  • Hong, S. B. and Raushel, F. M., Metal-substrate interactions facilitate the catalytic activity of the bac- terial phosphotriesterase. Biochemistry, 35, 10904– 10912, 1996.
  • Caldwell, S. R., Newcomb, J. R., Schlecht, K. A., and Raushel, F. M., Limits of diffusion in the hydrolysis of substrates by the phosphotriesterase fromPseudo-monas diminuta. Biochemistry, 30, 7438–7444, 1991.
  • Mackness, M. I., “A-esterases”. enzymes looking for a role? Biochem. Pharmacol., 38, 385–390, 1989.
  • Sogorb, M. A., Pla, A., and Vilanova, E., Las esterasas que hidrolizan compuestos organofosforados: un mecanismo eficaz de destoxificación. Rev. Toxicol., 13, 43–48, 1996.
  • Cheng, T. C., Harvey, S. P., and Chen, G. L., Cloning and expression of a gene encoding a bacterial enzyme for decontamination of organophosphorus nerve agents and nucleotide sequence of the enzyme. Appl. Environ. Microbiol., 62, 1636–1641, 1996.
  • Davies, J. A., Buchman, V. L., Krylova, O., and Ninkina, N. N., Molecular cloning and expression pattern of rpr–1, a resiniferatoxin-binding, phospho- triesterase-related protein, expressed in rat kidney tubules. FEBS Lett., 410, 378–382, 1997.
  • Eiberg, H. and Mohr, J., Genetics of paraoxonase. Ann. Hum. Genet., 45, 323–330, 1981.
  • Abbott, C. A., Mackness, M. I., Kumar, S., Boulton,A. J., and Durrington, P. N., Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol., 15, 1812–1818, 1995.
  • Schiavon, R., DeFanti, E., Giavarina, D., Biasioli, S., Cavalcanti, G., and Guidi, G., Serum paraoxonase activity is decreased in uremic patients. Clin. Chim. Acta., 247, 71–80, 1996.
  • Reiner, E., Simeon-Rudolf, V., and SkrinjaricSpoljar, M., Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera. Toxicol. Lett., 82/83, 447–52, 1995.
  • Mackness, M. I., Walker, C. H., and Carlson, L. A., Low A-esterase activity in serum of patients with fish- eye disease. Clin. Chem., 33(4),587–588, 1987.
  • Hou, X., Maser, R. L., Magenheimer, B. S., and Calvet, J. P., A mouse kidney- and liver-expressed cDNA having homology with a prokaryotic parathion hydrolase (phosphotriesterase)-encoding gene: abnor- mal expression in injured and polycystic kidneys. Gene, 168, 157–163, 1996.
  • Mackness, M. I. and Walker, C., Multiple forms of sheep serum A-esterase activity associated with the high- density lipoproteins. Biochem. J., 250, 539–545, 1988.
  • Mackness, M. I., Arrol, S., Abbott, C. A., and Durrington, P. N., Is paraoxonase related to athero- sclerosis. Chem. Biol. Interact., 87, 161–171, 1993.
  • Mackness, M. I., Arrol, S., and Durrington, P. N., Paraoxonase prevents accumulation of lipoperoxides in low-density Lipoprotein. FEBS Letters, 286, 152– 154, 1991.
  • Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., and Hegele, R. A., Paraoxonase: biochemistry, genetics and relationship to plasma li- poproteins. Curr. Opin. Lipidol., 7, 69–76, 1996.
  • Serrato, M. and Marian, A. J., A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest., 96, 3005–3008, 1995.
  • Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., and Lusis, A. J., Genetic-dietary regulation of serum para- oxonase expression and its role in atherogenesis in a mouse. J. Clin. Invest., 97, 1630–1639, 1996.
  • Navab, M., HamaLevy, S., VanLenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., and Fogelman, A. M., Mildly oxidized LDL induces an increased apolipo- protein J/paraoxonase ratio. J. Clin. Invest., 99(8),2005–2019, 1997.
  • Díaz., J., Céspedes, V., Molina, R., Sastre, J. F., Vilanova, E., and Carrera, V., No correlation be- tween paraoxonase activity and HDL levels in human serum in a local population. Toxicol. Lett., Suppl./88, 28–29, 1996.
  • Antikainen, M., Murtomaki, S., Syvanne, K. M., Pahlman, R., Tahvanainen, E., Jauhiainen, M., Frick, M. H., and Ehnholm, C., The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coro- nary artery disease in Finns. J. Clin. Invest., 98, 883– 885, 1996.
  • Suehiro, T., Nakauchi, Y., Yamamoto, M., Arii, K., Itoh, H., Hamashige, N., and Hashimoto, K., Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int. J. Cardiol., 57(1),69–73, 1996.
  • Mackness, M. I., Abbott, C., Arrol, S., and Durrington, P. N., The role of high-density lipopro- tein and lipid-soluble antioxidant vitamins in inhibit- ing low-density lipoprotein oxidation. Biochem. J., 294, 829–834, 1993.
  • Mackness, M. I., Arrol, S., Abbott, C., and Durrington, P. N., Protection of low-density lipopro- tein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis, 104(12),129–135, 1993.
  • Mackness, M. I. and Durrington, P. N., HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis, 115(2),243–253, 1995.
  • Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., Mclntyre,T. M., La Du, B. N., Fogelman, A. M., and Ber- liner, J. A., Effect of platelet-activating factor- acetylhy-drolase on the formation and action of mini- mally oxidised low-density lipoprotein. J. Clin. Invest., 95, 774–784, 1995.
  • Sultatos, L. G. and Murphy, S. D., Kinetics analyses of the microsomal biotransformation of the phos- phorothioate insecticides chlorpyrifos and parathion. Fundam. App. Toxicol., 3, 16–21, 1983.
  • Sultatos, L. G., The effects of phenobarbital pretreat- ment on the metabolism and acute toxicity on the pesticide parathion in the mouse. Toxicol. Appl. Pharmacol., 86, 105–111, 1986.
  • Soranno, T. M. and Sultatos, L. G., Bio- transformation of the insecticide parathion by mouse brain. Toxicol. Lett., 60, 27–37, 1992.
  • Wallace, K. B. and Dargan, J. E., Intrinsic meta- bolic clearance of parathion and paraoxon by livers from fish and rodents. Toxicol. Appl. Pharmacol., 90, 235–242, 1987.
  • Sultatos, L. G., Shao, M., and Murphy, S. D., The role of hepatic biotransformation in mechating the acute tox- icity of the phosphorothionate insecticide chlorpyrifos. Toxicol. Appl. Pharmacol., 73, 60–68, 1984.
  • Sultatos, L. G., Factors affecting the hepatic biotrans- formation of the phosphorothioate pesticide chlor- pyrifos. Toxicology, 51, 191–200, 1988.
  • Sultatos, L. G., Metabolic activation of the organo- phosphorus insecticides chlorpyrifos and fenitrothion by perfused rat liver. Toxicology, 68, 19, 1991.
  • Sultatos, L. G. and Minor, L. D., Metabolic activa- tion of the pesticide azinphos—methyl by perfused mouse livers. Toxicol. App. Pharmacol., 90, 227–234, 1987.
  • Chambers, J. E., Ma, T., Boone, J. S., and Cham- bers, H. W., Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. Life Sci., 54, 1357–1364, 1994.
  • Chambers, J. E. and Carr, R. L., Biochemical mechanisms contributing to species differences in insecticidal toxicity. Toxicology, 105, 291–304, 1995.
  • Butler, E. G., Eckerson, H. W., and La-Du, B. N., Paraoxon hydrolysis vs. covalent binding in the elimi- nation of paraoxon in the rabbit. Drug. Metab. Dispos., 13, 640–645, 1985.
  • La Du, B. N., Structural and functional diversity of paraoxonases [news]. Nat. Med., 2(11),1186–1187, 1996.
  • Walker, C. H. and Mackness, M. I., ‘A’ esterases and their role in regulating the toxicity of organophos- phates. Arch. Toxicol., 60, 30–33, 1987.
  • Jortner, B. S., Pope, A. M., and Heavner, J. E., Haloxoninduced delayed neurotoxicity: effect of plasma A (aryl) esterase activity on severity of lesions in sheep. Neurotoxicology, 4, 241–246, 1983.
  • Mortensen, S. R., Chanda, S. M., Hooper, M. J., and Padilla, S., Maturational differences in chlorpyrifos-oxonase activity may contribute to age- related sensitivity to chlorpyrifos. J. Biochem. Toxicol., 11, 279–287, 1996.
  • Li, W. F., Furlong, C. E., and Costa, L. G., Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett., 76, 219–226, 1995.
  • Li, W. F., Costa, L. G., and Furlong, C. E., Serum paraoxonase status: a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health, 40, 337–346, 1993.
  • Broomfield, C. A., A purified recombinant organo- phosphorus acid anhydrase protects mice against soman. Pharmacol. Toxicol., 70, 65–66, 1992.
  • Tuovinen, K., KalisteKorhonen, E., Raushel, F. M., and Hanninen, O., Phosphotriesterase — a promising candidate for use in detoxification of organophos- phates. Fundam. Appl. Toxicol., 23, 578–584, 1994.
  • KalisteKorhonen, E., Ylitalo, P., Hanninen, O., and Raushel, F. M., Phosphotriesterase decreases paraoxon toxicity in mice. Toxicol. Appl. Pharmacol., 121, 275– 278, 1993.
  • Tuovinen, K., KalisteKorhonen, E., Raushel, F. M., and Hanninen, O., Protection of organophosphate- inactivated esterases with phosphotriesterase. Fundam. Appl. Toxicol., 31(2),210–217, 1996.
  • Pei, L., Omburo, G., McGuinn, W. D., Petrikovics, I., Dave, K., Raushel, F. M., Wild, J. R., DeLoach,J. R., and Way, J. L., Encapsulation of phos- photriesterase within murine erythrocytes. Toxicol. Appl. Pharmacol., 124, 296–301, 1994.
  • Tuovinen, K., KalisteKorhonen, E., Raushel, F. M., and Hänninen, O., Eptastigmine-phosphotriesterase combination in DFP intoxication. Toxicol. Appl. Pharmacol., 140, 364–369, 1996.
  • Tuovinen, K., KalisteKorhonen, E., Raushel, F. M., and Hänninen, O., Phosphotriesterase, pralid-oxime- 2-chloride (2PAM) and eptastigmine treatments and their combinations in DFP intoxication. Toxicol. App. Pharmacol., 141, 555–560.
  • Benedict, M. Q., Scott, J. A., and Cockburn, A. F., High-level expression of the bacterial opd gene in Drosophila melanogaster: improved inducible insec- ticide resistance. Insect. Mol. Biol., 3, 247–252, 1994.
  • Hoskin, F. C. and Roush, A. H., Hydrolysis of nerve gas by squidtype diisopropyl phosphorofluoridate hydrolyzing enzyme on agarose resin. Science, 215, 1255–1257, 1982.
  • Caldwell, S. R. and Raushel, F. M., Detoxification of organophosphate pesticides using a nylon-based immobilized phosphotriesterase from pseudomonas diminuta. App. Biochem. Biotechnol., 31, 59–73, 1991.
  • Caldwell, S. R. and Raushel, F. M., Detoxification of Organophosphate Pesticides Using an Immobilized Phosphotriesterase from Pseudomonas diminuta. Biotech. Bioeng., 37, 103–109, 1991.
  • Watkins, L. M., Mahoney, H. J., McCulloch, J. K., and Raushel, F. M., Augmented hydrolysis of diisopropyl fluorophosphate in engineered mutants of phosphotriesterase. J. Biol. Chem., 272, 25596– 256601, 1997.
  • Watkins, L. M., Kuo, J. M., Chen-Goodspeed, M., and Raushel, F. M., A combinatorial library for the binuclear metal center of bacterial phosphotriesterase. Prot. Struct. Funct. Genet., 29, 553–561, 1997.
  • Rainina, E. I., Efremenco, E. N., Varfolomeyev,S. D., Simonian, A. L., and Wild, J. R., The devel- opment of a new biosensor based on recombinantE. coli for the direct detection of organophosphorus neurotoxins. Biosens. Bioelectron., 11, 991–1000, 1996.
  • Chiang, T., Dean, M. C., and McDaniel, C. S., A fruit fly bioassay with phosphotriesterase for detec- tion of certain organophosphorus insecticide residues. Bull. Environ. Contam. Toxicol., 34, 809–814, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.